Literature DB >> 19474352

Histological patterns in drug-induced liver disease.

R Ramachandran1, S Kakar.   

Abstract

The diagnosis of drug-induced liver injury (DILI) is a challenging problem, often confounded by incomplete clinical information and the difficulty of eliciting exposure to herbal products, over-the-counter agents and toxins. The task is further rendered difficult on biopsy, as drugs can mimic all the patterns found in primary liver disease. Acute hepatitis, with or without cholestasis, is the most common histological pattern of DILI, and drugs such as acetaminophen are the leading causes of acute liver failure. Most cases of DILI resolve on discontinuation of the drug, but recovery can take months or rarely the disease can progress despite drug withdrawal. Drugs such as methotrexate can lead to chronic hepatitis and cirrhosis, while others such as minocycline, nitrofurantoin and methyldopa are implicated in autoimmune hepatitis. Prolonged cholestasis and ductopenia resembling primary chronic biliary disease can occur. Drug-induced steatohepatitis is also an uncommon pattern, but is well described with drugs such as amiodarone and irinotecan. In the presence of risk factors such as obesity and diabetes, some drugs such as tamoxifen, oestrogens and nifedipine can precipitate or exacerbate steatohepatitis. Other observed patterns include granulomatous hepatitis, vascular injury (eg, sinusoidal obstruction syndrome), Ito cell lipidosis and neoplasms (eg, adenomas).

Entities:  

Mesh:

Year:  2009        PMID: 19474352     DOI: 10.1136/jcp.2008.058248

Source DB:  PubMed          Journal:  J Clin Pathol        ISSN: 0021-9746            Impact factor:   3.411


  77 in total

1.  Drug-induced autoimmune-like hepatitis: a diagnostic challenge.

Authors:  Agustin Castiella; Maria Isabel Lucena; Eva Maria Zapata; Pedro Otazua; Raul J Andrade
Journal:  Dig Dis Sci       Date:  2011-08       Impact factor: 3.199

2.  Metabolic activation and analgesic effect of flupirtine in healthy subjects, influence of the polymorphic NAT2, UGT1A1 and GSTP1.

Authors:  Werner Siegmund; Christiane Modess; Eberhard Scheuch; Karen Methling; Markus Keiser; Ali Nassif; Dieter Rosskopf; Patrick J Bednarski; Jürgen Borlak; Bernd Terhaag
Journal:  Br J Clin Pharmacol       Date:  2015-03       Impact factor: 4.335

3.  Drug-induced liver injury: Asia Pacific Association of Study of Liver consensus guidelines.

Authors:  Harshad Devarbhavi; Guruprasad Aithal; Sombat Treeprasertsuk; Hajime Takikawa; Yimin Mao; Saggere M Shasthry; Saeed Hamid; Soek Siam Tan; Cyriac Abby Philips; Jacob George; Wasim Jafri; Shiv K Sarin
Journal:  Hepatol Int       Date:  2021-02-27       Impact factor: 6.047

4.  A case of acute interstitial nephritis and granulomatous hepatitis induced by ingesting quinine.

Authors:  Ai Katsuma; Maki Shibata; Takashi Katsuki; Eri Imai; Manami Tada; Fumihiko Hinoshita
Journal:  CEN Case Rep       Date:  2014-08-29

5.  Mitogen-activated protein kinase phosphatase (Mkp)-1 protects mice against acetaminophen-induced hepatic injury.

Authors:  Lyn M Wancket; Xiaomei Meng; Lynette K Rogers; Yusen Liu
Journal:  Toxicol Pathol       Date:  2012-05-23       Impact factor: 1.902

Review 6.  Drug Hypersensitivity.

Authors:  Ruwen Böhm; Ehrhardt Proksch; Thomas Schwarz; Ingolf Cascorbi
Journal:  Dtsch Arztebl Int       Date:  2018-07-23       Impact factor: 5.594

7.  Clinical associations of hepatic stellate cell (HSC) hyperplasia.

Authors:  Taofic Mounajjed; Rondell P Graham; Schuyler O Sanderson; Thomas C Smyrk
Journal:  Virchows Arch       Date:  2014-05-09       Impact factor: 4.064

Review 8.  Adverse reactions to targeted and non-targeted chemotherapeutic drugs with emphasis on hypersensitivity responses and the invasive metastatic switch.

Authors:  Brian A Baldo; Nghia H Pham
Journal:  Cancer Metastasis Rev       Date:  2013-12       Impact factor: 9.264

9.  Role for cytoplasmic nucleotide hydrolysis in hepatic function and protein synthesis.

Authors:  Benjamin H Hudson; Joshua P Frederick; Li Yin Drake; Louis C Megosh; Ryan P Irving; John D York
Journal:  Proc Natl Acad Sci U S A       Date:  2013-03-11       Impact factor: 11.205

10.  Liver cancer initiation is controlled by AP-1 through SIRT6-dependent inhibition of survivin.

Authors:  Lihua Min; Yuan Ji; Latifa Bakiri; Zhixin Qiu; Jin Cen; Xiaotao Chen; Lingli Chen; Harald Scheuch; Hai Zheng; Lunxiu Qin; Kurt Zatloukal; Lijian Hui; Erwin F Wagner
Journal:  Nat Cell Biol       Date:  2012-10-07       Impact factor: 28.824

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.